28 results
SC 14D9/A
PNT
POINT Biopharma Global Inc.
18 Dec 23
Tender offer solicitation (amended)
8:14am
of which is then capable of being satisfied), other than the Antitrust Condition, the NRC Condition and the condition requiring the absence of any Legal
SC 14D9/A
PNT
POINT Biopharma Global Inc.
4 Dec 23
Tender offer solicitation (amended)
7:22am
are to be satisfied at the Acceptance Time, each of which is then capable of being satisfied), other than the Antitrust Condition, the NRC Condition
SC 14D9/A
PNT
POINT Biopharma Global Inc.
17 Nov 23
Tender offer solicitation (amended)
7:05am
that by their nature are to be satisfied at the Acceptance Time, each of which is then capable of being satisfied), other than the Antitrust
SC 14D9/A
PNT
POINT Biopharma Global Inc.
8 Nov 23
Tender offer solicitation (amended)
5:28pm
that by their nature are to be satisfied at the Acceptance Time, each of which is then capable of being satisfied), other than the Antitrust Condition … :
The last paragraph under the subsection titled “U.S. Antitrust Laws” within the section titled “Regulatory Approvals” on page 43 is hereby deleted
SC TO-T/A
lqal7m9alyump
8 Nov 23
Third party tender offer statement (amended)
5:06pm
SC 14D9
jth233
13 Oct 23
Tender offer solicitation
7:11am
SC TO-T
EX-99
wqb10j7
13 Oct 23
Third party tender offer statement
6:52am
SC TO-T
EX-99
ha183n x4vxz
13 Oct 23
Third party tender offer statement
6:52am
SC14D9C
u2rda no8qbhvb4itiv
3 Oct 23
Written communication relating to third party tender offer
7:37am
SC14D9C
EX-2.1
0gcp80
3 Oct 23
Written communication relating to third party tender offer
7:37am
8-K
2xjdtsc
3 Oct 23
Tender and Support Agreement
7:35am
8-K
EX-2.1
0lbby 0uh8s6s
3 Oct 23
Tender and Support Agreement
7:35am
ARS
vt087
1 May 23
Annual report to shareholders
1:52pm
424B3
vhov zc5yq8z
9 Jun 21
Prospectus supplement
4:42pm